Document is current
Any future updates will be listed below
-
Authors
Anttalainen, Anna
Havula, Essi
Kysenius, Kai
Toppila, Iiro
Miettinen, Tatu
Lassenius, Mariann
Silvennoinen, Raija
Partanen, Anu
Putkonen, Mervi
-
Funding
Funding for this research was provided by:
Takeda Oy
- License Information
-
More Information
Article History
Received: 20 September 2024
Accepted: 14 November 2024
First Online: 16 December 2024
Declarations
:
: AA, EH, KK, IT, and MIL are employees of Medaffcon Oy. TM was an employee of Takeda Finland and Medaffcon Oy. RS has received research funding, administered by Hospital Science Centers, from Amgen, BMS, Celgene, Janssen-Cilag and Takeda and honoraria from the same companies (Advisory Board and presentations).AP reports honoraria from Behring and Abbvie and has participated in Scientific Advisory Board meetings organized by Abbvie, Janssen-Cilag, Novartis, Pfizer and Takeda. MP has received honoraria from Amgen, Celgene, Janssen-Cilag and Takeda (Advisory Board and presentations).
: The study was approved by Findata, permission THL/3276/14.02.00/2021 and Statistics Finland, permission TK/1449/07.03.00/2022, in accordance with the act on the secondary use of health and welfare data in Finland.
